BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17118865)

  • 1. Costs in primary care of investigating symptoms suspicious of cancer in a defined population.
    Månsson J; Marklund B; Carlsson P
    Scand J Prim Health Care; 2006 Dec; 24(4):243-50. PubMed ID: 17118865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care. A retrospective study from the primary health care centre area of Kungsbacka, Sweden.
    Månsson J; Björkelund C; Hultborn R
    Neoplasma; 1999; 46(2):93-9. PubMed ID: 10466432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of heart failure in Swedish primary healthcare.
    Agvall B; Borgquist L; Foldevi M; Dahlström U
    Scand J Prim Health Care; 2005 Dec; 23(4):227-32. PubMed ID: 16272071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource use and costs associated with different states of breast cancer.
    Lidgren M; Wilking N; Jönsson B; Rehnberg C
    Int J Technol Assess Health Care; 2007; 23(2):223-31. PubMed ID: 17493308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer--prevalence-based healthcare costs.
    Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
    Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
    Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
    Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptom presentation in cancer patients in general practice].
    Nielsen TN; Hansen RP; Vedsted P
    Ugeskr Laeger; 2010 Oct; 172(41):2827-31. PubMed ID: 20961502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
    Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B
    Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis applied to the treatment of burn patients in a specialized center.
    Sánchez JL; Perepérez SB; Bastida JL; Martínez MM
    Arch Surg; 2007 Jan; 142(1):50-7; discussion 57. PubMed ID: 17224500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
    Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of colorectal cancer before emergency presentation: a population-based case-control study.
    Cleary J; Peters TJ; Sharp D; Hamilton W
    Fam Pract; 2007 Feb; 24(1):3-6. PubMed ID: 17142248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.